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Both plants and animals require the activity of proteins contain-
ing nucleotide binding (NB) domain and leucine-rich repeat (LRR)
domains for proper immune system function. NB-LRR proteins in
plants (NLR proteins in animals) also require conserved regula-
tion via the proteins SGT1 and cytosolic HSP90. RAR1, a protein
specifically required for plant innate immunity, interacts with
SGT1 and HSP90 to maintain proper NB-LRR protein steady-state
levels. Here, we present the identification and characterization
of specific mutations in Arabidopsis HSP90.2 that suppress all
known phenotypes of rar1. These mutations are unique with
respect to the many mutant alleles of HSP90 identified in all
systems in that they can bypass the requirement for a cochap-
erone and result in the recovery of client protein accumulation
and function. Additionally, these mutations separate HSP90 ATP
hydrolysis from HSP90 function in client protein folding and/or
accumulation. By recapitulating the activity of RAR1, these novel
hsp90 alleles allow us to propose that RAR1 regulates the
physical open– close cycling of a known ‘‘lid structure’’ that is
used as a dynamic regulatory HSP90 mechanism. Thus, in rar1, lid
cycling is locked into a conformation favoring NB-LRR client
degradation, likely via SGT1 and the proteasome.
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P lants have evolved a highly complex immune system centeredon pathogen recognition via the evolutionarily-conserved
NB-LRR proteins. Pathogen-triggered activation of NB-LRR
proteins leads to several responses, including cell wall strength-
ening, transcriptional reprogramming, and a form of pro-
grammed cell death termed the hypersensitive response (HR).
Because their function often results in cell death, proper main-
tenance of NB-LRR protein levels and activation state are vital
to the health of the plant (1).
NB-LRR proteins can be divided into 2 structural subgroups
based on the presence of either a likely coiled-coil (CC) or Toll
interleukin-1 receptor (TIR) domain at their N termini. Either of
these N-terminal domains is followed in both subgroups by a middle
nucleotide binding (NB) site and a C-terminal leucine-rich repeat
(LRR). This general structure is not only conserved across all plants
but extends to NOD/Caterpiller/NLR proteins that mediate various
processes in mammalian innate immunity (2).
Just as the domain composition of these intracellular receptors
is conserved from plants to animals, so is the regulation of their
steady-state accumulation. Cytosolic HSP90 and the cochaper-
one SGT1 have been previously demonstrated to not only be
important for regulation of NB-LRR proteins in plants, but also
in regulation of NLR function in animals (3). A third protein
called RAR1 appears to play a role in innate immunity specif-
ically in plants (4).
All 3 of these proteins can independently interact with one
another; the CS domain of SGT1b, or the CHORDI domain of
RAR1, can interact with the N-terminal ATPase domain of
HSP90; the CHORDII domain of RAR1 also interacts with the
CS domain of SGT1 (5). The interaction of SGT1 with HSP90
has been shown to be required for SGT1 function (6). Mutation
of SGT1 can suppress rar1 for some NB-LRR functions, but not
all (7). However, the relationship between RAR1 and HSP90 is
less understood.
We present and characterize specific missense alleles of
HSP90.2 in the reference plant, Arabidopsis, that suppress rar1.
These hsp90.2 alleles are uniquely interesting in that they can
bypass the requirement for a cochaperone and result in recovery
of client protein accumulation and function.
We used genetic and biochemical analyses to demonstrate that
these hsp90.2 mutant proteins act on NB-LRR proteins affected
by rar1, suppressing all identified rar1 phenotypes. We further
show that these mutations are functionally distinct from previ-
ously-identified hsp90.2 mutations (8), including a null allele.
These specific missense changes in hsp90.2 enable a separation
of HSP90 ATP hydrolysis activity and HSP90 function in client
protein accumulation. By recapitulating the activity of RAR1 in
its absence, the phenotypes of these hsp90.2 mutants strongly
suggest that RAR1 physically enhances the transition state of
HSP90 as it moves from a ‘‘lid open’’ ADP-bound conformation
to a ‘‘lid closed’’ ATP-bound conformation.
Results
Identification of Alleles of RAR1 and HSP90. To identify new genes
required for RPM1 function in Arabidopsis, we performed 2
genetic screens. Both took advantage of sensitized genetic
backgrounds. The first was a modification of a previous screen
(9), using a -estradiol-inducible copy of the avrRpm1 bacterial
type III effector gene whose product is recognized in Arabidopsis
by the RPM1 NB-LRR protein (Fig. S1 A). Given the very high
recovery ratio of rpm1 alleles compared with second-site loci
isolated previously (9), we modified the screen by crossing into
this background a well-characterized transgenic, myc-epitope
tagged copy of RPM1 expressed from the native promoter (Fig.
S1A and ref. 10). Approximately 1 million M2 plants were
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screened from 200 ethyl methanesulfonate (EMS)-mutagenized
seed lots. Putative surviving mutants were then assayed for loss
of disease resistance in response to pathogen-delivered Avr-
Rpm1 to eliminate mutations in the estradiol-inducible system
(see Materials and Methods).
Various candidate genes previously implicated in RPM1 func-
tion were then sequenced in the remaining putative mutants.
They included the endogenous copy of RPM1, the transgenic
copy of RPM1-myc, RAR1, and all 4 genes encoding Arabidopsis
cytosolic HSP90 (8–11). Four mutations in RAR1 and 1 allele of
HSP90.2 were found, hsp90.2–6 (Fig. S2). The rar1 alleles are
consistent with previous mutations: premature stops, splicing
defects, and disruption of zinc-coordinating residues (12, 13). The
allele of hsp90.2 displayed intermediate susceptibility and full
penetrance, as previously found for hsp90.2–1 and hsp90.2–3 (8).
Mutations were not found in these loci in the remaining mutants.
The second screen was a rar1 suppressor screen, aimed at
identifying loci that would restore the loss of NB-LRR protein
accumulation, and the consequent loss of NB-LRR function,
that are the principal rar1 phenotypes (13). Approximately
200,000 EMS-mutagenized M2 individuals from 50 M1 seed lots
of rar1–21 were spray-inoculated with Pto DC3000(avrPphB)
(see Materials and Methods). This strain is recognized in Arabi-
dopsis by the RPS5 NB-LRR protein (14). We used RPS5 as the
read-out in this screen because rar1 exhibits a strong and uniform
disease susceptibility phenotype to Pto DC3000(avrPphB). We
reasoned that a suppressor would be obviously disease resistant
against this susceptible background.
We identified 5 independent second-site mutants defining 3
loci in this screen. Although hsp90.2 has previously been shown
to have no effect on RPS5 (8), 2 of the mutants are missense
mutations in the hsp90.2 gene based on map-based cloning and
subsequent sequencing of both mutant alleles (Fig. S2B). The
other 2 loci will be discussed elsewhere. To avoid confusion, we
will henceforth refer to hsp90.2 alleles that lose RPM1 function
by the original notation, lra (loss of recognition of avrRpm1)
(13), and alleles that suppress rar1 as rsp (rar1 suppressor). Like
all of the lra alleles, hsp90.2–7rsp is completely recessive. How-
ever, based on disease symptoms after bacterial inoculation,
hsp90.2–8rsp behaves as a weak semidominant allele (see Mate-
rials and Methods).
hsp90.2rsp Alleles Suppress all Known rar1 Phenotypes. Inexplicably,
hsp90.2lra alleles were previously shown to specifically impact
RPM1 function, and not the function of other tested NB-LRR
proteins (8). Conversely, rar1 affects the steady-state accumu-
lation of all tested NB-LRR proteins, and the function of many,
by lowering their accumulation below a functional threshold (7,
15). Hence, we did not expect to identify hsp90.2 alleles in our
RPS5-based rar1 suppressor screen. We determined whether the
rsp alleles suppressed rar1 phenotypes of other NB-LRR-
dependent disease resistance specificities. The hsp90.2rsp alleles
variably suppressed rar1 with respect to RPS5 function (Fig. 1A),
RPM1 function (Fig. 1B), and RPS2 function (Fig. 1C).
rar1 mutants express decreased basal disease resistance to the
virulent pathogen Pto DC3000 (7). The only molecular pheno-
type ever ascribed to rar1 is diminution of steady-state NB-LRR
protein accumulation as noted above. Thus, this phenotype
suggests an as-yet-undocumented role for RAR1 on NB-LRR
proteins that might either function in basal defense and/or weak
recognition of the type III effectors delivered by Pto DC3000
(16). Notably, both hsp90.2rsp alleles also suppress this phenotype
(Fig. 1D).
We used the release of ions into solution by inoculated plant
leaf discs to measure the ability of hsp90.2rsp to suppress the loss
of HR associated with rar1 (17). Although neither rpm1 nor rar1
are able to generate an HR upon delivery of AvrRpm1, rar1
hsp90.2rsp double mutants display the same level of HR as
wild-type Col-0 plants (Fig. 1E). The suppression of this partic-
ular rar1 phenotype is in marked contrast to results obtained with
sgt1b as a rar1 suppressor (7).
We next assayed whether the hsp90.2rsp alleles were able to
suppress the most direct rar1 mutant phenotype, a decrease in
NB-LRR protein accumulation (13). We introgressed a trans-
genic RPM1-myc-epitope-tagged derivative driven from its na-
tive promoter (10) into each hsp90.2rsp rar1 mutant. In these
double mutants, the hsp90.2rsp alleles suppressed the very low
RPM1 accumulation observed in rar1 (Fig. 1F). Hence, the
hsp90.2rsp alleles suppress the key biochemical phenotype of rar1,
at least with respect to RPM1 and probably more generally, given
the pathology data presented in Fig. 1.
Because RPM1, RPS2, and RPS5 are CC-NB-LRR proteins,
we addressed whether a RAR1-dependent, TIR-NB-LRR pro-
tein is also suppressed by the hsp90.2rsp alleles. RPP4 conditions
disease resistance to the oomycete pathogen, Hyaloperonospora
arabidopsidis (Hpa) (18). In this case, the HR is likely to be
required for disease resistance, whereas it is likely to be dis-
pensable for resistance to bacterial pathogens. We noted that
both hsp90.2rsp rar1 lines expressed higher RPP4 function than
rar1 (Fig. S3A) and exhibited higher levels of HR (Fig. S3B).
Hence, the hsp90.2rsp alleles also suppress rar1 for a TIR-NB-
LRR and in a context where HR is likely to be the key
mechanism of disease resistance.
The possibility existed that the recovery of disease resistance
Fig. 1. rsp alleles suppress all known rar1 phenotypes. (A–D) Bacterial
growth assays comparing rar1 mutants to hsp90.2rsp rar1 double mutants.
Note the logarithmic scale. hsp90.2rsp mutants suppress rar1 phenotypes for
disease resistance mediated by RPS5 (A), RPM1 (B), and RPS2 (C). (D) hsp90.2rsp
mutants suppress the rar1 phenotype of decreased basal resistance to Pto
DC3000 (7). (E) hsp90.2rsp alleles suppress the rar1 phenotype of loss of
RPM1-mediated HR. An increase in conductivity is indicative of the release of
ions from cells undergoing HR. (F) hsp90.2rsp alleles suppress the rar1 pheno-
type of lowered steady-state accumulation of RPM1-myc protein.





















observed in hsp90.2rsp rar1 double mutants is not specific, but
rather a result of general metabolic perturbation resulting in
disease resistance. Such perturbations are typically accompanied
by an increase in the levels of defense marker proteins such as
PR-1 (19). However, we did not observe an obvious increase in
PR-1 levels in hsp90.2rsp lines.
We previously demonstrated that a presumed truncated pro-
tein product made by the rar1–21 allele used as the parent in this
screen, which would express only CHORD-I, is, surprisingly,
able to coimmunoprecipitate HSP90. This coimmunoprecipita-
tion was not observed with the rar1–20 null allele or the W47stop
allele, rar1–28 (ref. 8 and Y. Belkhadir, personal communica-
tion). We constructed rar1–28 hsp90.2rsp combinations for both
rsp alleles. We assayed for RPM1 function to rule out the
possibility of a rar1 allele-specific effect. We clearly observed
suppression of the rar1 phenotype in rar1–28 hsp90.2rsp double
mutants; hence the effect of the rsp alleles on RPM1 function is
not rar1–21 allele specific.
hsp90.2rsp Alleles Have No Phenotype in RAR1. We isolated the
hsp90.2rsp single mutants by backcrossing and assayed them for
RPM1 function. As seen in Fig. 2A, the hsp90.2rsp single mutants
express wild-type RPM1 function. Hence, the hsp90.2rsp single
mutants are phenotypically distinct from the hsp90.2lra alleles
(8), which all express partial loss of RPM1-mediated disease
resistance. We also monitored HR in the hsp90.2rsp single
mutants. hsp90.2rsp alleles again expressed wild-type phenotypes
(Fig. 2B).
The HSP90.2rsp proteins might counterbalance the decrease in
NB-LRR protein accumulation observed in rar1 by conditioning
‘‘hyperaccumulation’’ above wild-type levels. We thus intro-
gressed RPM1-myc into each hsp90.2rsp mutant and assayed for
RPM1-myc protein accumulation. We detected wild-type
RPM1-myc protein levels in the single mutant lines. We con-
clude that there is no increased NB-LRR protein activity indic-
ative of ‘‘hyperchaperoning’’ by the hsp90.2rsp alleles. Thus, these
alleles are true suppressors of the loss of RAR1 molecular
activity and are not merely overcoming the rar1 phenotype by
increased overall expression of client protein.
hsp90.2lra and hsp90.2KO Alleles Do Not Suppress rar1. We next tested
whether either hsp90.2KO or a reference hsp90.2–3lra allele
(encoding D80N, a mutation analogous to the well-studied yeast
D79N; ref. 20) could suppress rar1 for RPM1 function. We
constructed the appropriate double mutants and noted that both
were as susceptible to Pto DC3000(avrRpm1) as rar1 (Fig. 3A).
Conductivity measurements of RPM1-mediated HR in these
double mutants (Fig. 3B) gave similar results, supporting the
conclusion that neither hsp90.2KO nor an hsp90.2–3lra allele can
suppress rar1. Thus, the hsp90.2rsp alleles are also phenotypically
distinct from both a null allele (Fig. 3) and the classic ATPase
dead hsp90.2–3lra (Figs. 2 and 3).
hsp90.2rsp Alleles Are Not Null Alleles. Although both hsp90.2rsp
alleles encode missense changes, there remained a possibility
that they are functionally null. If so, then 1 of the 3 remaining
cytosolic HSP90 proteins might compensate for the loss of
HSP90.2 in these alleles, as previously noted for hsp90.2KO (8).
Arabidopsis has 4 genes encoding cytosolic HSP90, 3 of which,
including HSP90.2, reside in a cluster. The fourth, HSP90.1, lies
1.3 Mbp away on the same chromosome. We wanted to
establish whether stepwise elimination of HSP90 function would
reveal null phenotypes, which we could then compare with
hsp90.2–3lra and hsp90.2–7rsp alleles. We were unable to recover
hsp90.2–5KO hsp90.1KO double mutants. However, we did iden-
tify plants homozygous for hsp90.1KO and heterozygous for
hsp90.2–5KO. These were stunted and expressed high accumu-
lation of anthocyanins, loss of apical dominance, and very low
fecundity. Selfed progeny segregated lethals. Hence, HSP90.1 is
synthetically lethal with HSP90.2, suggesting that the overall
level of cytosolic HSP90 has a minimum threshold for viability.
Importantly, we were able to obtain hsp90.2–3lra hsp90.1KO,
hsp90.2–7rsp hsp90.1KO, and hsp90.2–8rsp hsp90.1KO double mu-
tants. These were viable and as healthy as either single mutant.
Fig. 2. hsp90.2rsp mutants are phenotypically distinct from an hsp90.2lra
single mutant and an hsp90.2 T-DNA insertion null mutant. hsp90.2rsp,
hsp90.2lra, and hsp90.2KO single mutant plants are compared with each other
and Col-0 and rpm1 plants. (A) Bacterial growth assay for recognition of Pto
DC3000(avrRpm1) by RPM1. (B) Conductivity assay measuring the HR trig-
gered by RPM1 activation after recognition of AvrRpm1.
Fig. 3. Neither an hsp90.2lra allele nor the hsp90.2KO null allele suppress rar1.
(A) Bacterial growth assay measuring disease resistance to Pto DC3000 (avr-
Rpm1) mediated by RPM1. Wild-type Col-0 and rar1 mutant plants are com-
pared with hsp90.2–3lra rar1 and hsp90.2KO rar1 double mutants. (B) Conduc-
tivity assay measuring the HR to Pto DC3000 (avrRpm1).
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Hence, hsp90.2–3lra, hsp90.2–7rsp, and hsp90.2–8rsp maintained
the HSP90 activity required to support proper growth and
development in the absence of HSP90.1.
We thus conclude that none of the tested rsp or lra alleles are
null for HSP90 activity. Our collected genetic data strongly
suggest that the hsp90.2rsp alleles are active, and that they
recapitulate the molecular activity of RAR1 on client NB-LRR
accumulation.
Analysis of Interactions Between hsp90.2 Mutant Proteins with RAR1
and SGT1. Given the correlation between the region of HSP90
mutated in both of our genetic screens and the region of HSP90
that physically interacts with RAR1 and SGT1 (see Introduc-
tion), we were interested in finding out whether our HSP90
mutants were affected in their ability to interact with RAR1 and
SGT1 in the yeast 2-hybrid system. As shown in Fig. 4, wild-type
HSP90.2 can interact with both RAR1 and SGT1b, but not
SGT1a, which is consistent with previously-published coimmu-
noprecipitation experiments (8). Hence, this system is likely to
accurately reflect in vivo interactions in Arabidopsis.
We found that all 4 of the hsp90.2lra proteins lost interaction
with SGT1b in yeast 2-hybrid (Fig. 4C). Three lost interaction
with RAR1 (Fig. 4A). The exception was S100F (hsp90.2–2lra),
previously noted (8) to be partially penetrant, which maintained
a strong interaction with RAR1. The 2 rsp mutant proteins
exhibited opposing RAR1 and SGT1b interactions. The A11T
(hsp90.2–7rsp) protein maintained strong interactions with both
RAR1 and SGT1b. However, the R337C (hsp90.2–8rsp) protein
lost the ability to interact with both RAR1 and SGT1b. None
interacted with SGT1a (Fig. 4B), indicating that this protein is
likely to be irrelevant to HSP90.2 function. Western blot analysis
showed that all mutant proteins were expressed equally well in
yeast (Fig. 4D). The loss of interaction between R337C (hsp90.2–
8rsp) and both RAR1 and SGT1b suggests that these interactions
are not necessary for restoration of NB-LRR function in this allele.
This result is consistent with restoration of several different RAR1-
dependent NB-LRR functions in rar1 sgtb double mutants (7).
We were unable to observe an interaction between HSP90.2
and any tested fragment of RPM1 by yeast 2-hybrid analysis.
However, we did see a strong interaction between GST-HSP90
fusion purified from Escherichia coli and an HA epitope-tagged
version of RPM1 produced via in vitro transcription and trans-
lation in wheat germ lysates (21). Using this system, we did not
observe any difference in the ability of lra or rsp mutant HSP90.2
proteins to interact with RPM1. Hence, it is unlikely that an
overall change in NB-LRR protein interaction with HSP90
causes the various hsp90.2 mutant phenotypes.
ATPase Activity Is Not Predictive of HSP90 Activity in NB-LRR Function.
All hsp90.2 missense alleles obtained from our 2 screens were
either located in the ATPase domain itself or in the case of
R337Crsp in a part of the middle domain physically adjacent to
the ATPase domain in the HSP90 crystal structure (Fig. S4).
Thus, differences in ATPase activity associated with the N-
terminal HSP90 domain (22) might also explain the different
properties of the mutant HSP90.2 proteins. We purified recom-
binant wild-type HSP90.2 and all of the lra and rsp variants (see
Materials and Methods). Circular dichroism analyses of the
purified proteins showed that all variants had an equivalent
proportion of -helix and -sheet indicative of proper folding.
The ability of these proteins to hydrolyze ATP was measured in
an ATP-regenerating system (see Materials and Methods).
Nearly all of the hsp90.2–8lra alleles are missense changes in
amino acids that contact bound nucleotide in the crystal struc-
ture, and D80N (hsp90.2–3lra; D79N in ScHSP90) loses ATP
hydrolysis. Hence, it was unsurprising that these proteins lacked
ATPase activity (Fig. 5). R337C (hsp90.2–8rsp) expressed only
very weak ATPase activity (2-fold above negative control).
Surprisingly, A11T (hsp90.2–7rsp), maintained full ATPase ac-
tivity, but with a 5-fold increase in the observed KM [wild
type  0.04 M  0.01; A11T (hsp90.2–7rsp)  0.20 M  0.05].
However, plant cytosolic ATP concentrations were 3 mM (23),
suggesting that the change in KM is probably not relevant to the
phenotype exhibited by the mutant. Addition of RAR1 and/or
SGT1b to these assays did not alter ATPase activity; this negative
result may merely mean that we lack other required conditions
and/or components for in vitro reconstruction.
N-Terminal Dimerization Is Retained in hsp90.2rsp Proteins. Yeast
HSP90 functions as a dimer formed via separate N-terminal and
C-terminal dimerization domains. In yeast, N-terminal dimer-
ization is mediated by a short-N-terminal stretch of each mono-
mer (Fig. S4) and requires ATP binding (24). Using the same
Fig. 4. Interactions between hsp90.2 mutant proteins and RAR1 or SGT1b
does not correlate with phenotype. (A–C) -Galactosidase assay quantification
of the results of yeast 2-hybrid interaction measurements between HSP90.2
and mutant variants with RAR1 (A), SGT1a (B), or SGT1b (C). (D) HSP90.2 and
mutant variants accumulate to equivalent levels in yeast as measured by
Western blot. RAR1 interacts normally with SGT1a in this assay.
Fig. 5. HSP90 ATPase activity does not predict hsp90.2 mutant phenotype. In
vitro ATPase activity of HSP90.2 and mutant variants with a range of ATP
concentrations was used to determine the Kcat. HSP90 concentration was 5
M, and ATP concentrations ranged between 0 and 1.2 mM (see Materials and
Methods).





















assay, we found that dimerization of full-length Arabidopsis
HSP90.2 depended on the presence of the nonhydrolyzable ATP
analogue, adenosine 5-[,-imido]triphosphate (AMP-PNP).
We did not observe HSP90.2 dimers in the absence of AMP-PNP
or the presence of ADP. We also tested purified lra and rsp
HSP90 mutant proteins for dimerization. The lra mutant variants
were unable to dimerize in the presence of any tested nucleotide
(Fig. 6A) The rsp mutant variants could dimerize, A11T
(hsp90.2–7rsp) more than R337C (hsp90.2–8rsp), but both less
than wild type (Fig. 6B). Addition of RAR1 and/or SGT1b to
these assays did not alter dimerization activity under these
conditions. Hence, ATP binding is required for Arabidopsis
HSP90 dimerization.
The proportion of HSP90.2 that we observed in the dimerized
form was low compared with the results reported for yeast
HSP90 (24). It is unclear whether this was caused by our buffer
conditions or it is an intrinsic property of Arabidopsis HSP90.2.
However, this lower proportion of dimer was not caused by our
cross-linking conditions, because increasing the concentration of
cross linker 10-fold did not result in an increased proportion
of dimerized HSP90.2.
In yeast, an ATP-independent C-terminal domain is sufficient
(defined using N-terminal truncations), but not necessary (de-
fined using C-terminal truncations), for HSP90 dimerization
(25). Given our dimerization results and the positions of the rsp
mutations on HSP90.2, we wanted to make sure that we were
assaying the ATP dependent N-terminal activity in our assay. We
purified HSP90.2 containing a short C-terminal truncation,
known to abolish ATP-independent dimerization in yeast HSP90
(see Materials and Methods and ref. 24). This protein was unable
to dimerize, even in the presence of AMP-PNP (Fig. S5). We
thus conclude that the C-terminal dimerization domain of
Arabidopsis HSP90.2 is necessary, but not sufficient (e.g., as in
the cases where the N-terminal domain is mutated), for dimer-
ization of Arabidopsis HSP90.2 and that the dimerization we
measured was caused by the N-terminal domain.
Discussion
We performed 2 genetic screens to identify components affect-
ing RPM1-mediated disease resistance in Arabidopsis. We dem-
onstrate here that 2 specific hsp90.2 mutations suppress rar1 and
restore NB-LRR protein accumulation, and hence, function.
These hsp90.2rsp alleles demonstrate that HSP90.2 plays a
broader role in disease resistance in Arabidopsis than previously
considered (8). The hsp90.2rsp alleles are unique in 3 ways: (i)
The particular mutations, A11T and R337C, have not been
identified in any genetic screen, although the residues are strictly
conserved across all eukaryotic species. (ii) These mutations
translate into HSP90 proteins that bypass the requirement for a
cochaperone. (iii) Most importantly, these mutations result in
HSP90 alleles that result in a recovery of client protein accu-
mulation and function (Table S1). The particular features of the
hsp90.2rsp alleles, together with emerging structural analyses of
HSP90 and its cochaperones, allow us to examine HSP90 func-
tion and propose an explicit mechanism for the function of the
RAR1 cochaperone in NB-LRR protein stabilization.
hsp90.2–7rsp is recessive and encodes an A11T change.
hsp90.2–8rsp is weakly semidominant and encodes a R337C
change. Both suppress all known rar1 phenotypes to similar
degrees. For example, both partially suppress rar1 for RPS5
function and fully suppress rar1 for RPM1 and RPS2 function,
as measured by restoration of HR and pathogen growth restric-
tion. They also suppress the rar1-enhanced disease susceptibility
phenotype. Most importantly, both restore accumulation of
RPM1-myc in rar1. Neither rsp allele has any discernible phe-
notype in the presence of RAR1. Neither expresses enhanced
RPM1 activity in the presence of RAR1. Both provide some
level of HSP90.2 function, at least as it pertains to viability in the
context of a decrease in overall HSP90 levels. We used these 2
hsp90.2rsp alleles and the 4 previously-identified hsp90lra alleles
(8) in a variety of tests designed to address how they might
differentially influence 3 properties of HSP90: interaction with
RAR1 and SGT1b, ATPase activity, and HSP90 dimerization. The
rsp mutant proteins have different properties in these assays, as
noted in Results, although both can dimerize to differing degrees.
The rsp alleles allowed us to examine the relationship between
HSP90 ATPase activity and HSP90 function. It has long been
assumed that ATPase activity is required for HSP90 function
(26, 27). The data presented here argue against this concept in
2 ways. First, R337C (hsp90.2–8rsp) restores NB-LRR accumu-
lation in rar1, yet the R337C mutation exhibits a nearly full loss
of ATPase activity. Further, R337C is a more efficient suppres-
sor of rar1 than A11T based on its semidominance, yet it
nevertheless has lower ATPase activity than A11T. Hence, at
least in the absence of RAR1, high ATPase activity is not
required for NB-LRR accumulation. Second, D80N (hsp90.2–
3lra), which is unable to bind ATP, does provide some function,
to the extent that the hsp90.2–3lra hsp90.1KO double mutant was
viable, and expresses no novel phenotype. In fact, given the
nearly lethal phenotype observed with a half-dose of HSP90.2 in
the absence of HSP90.1 the D80N mutation must exhibit more
than half the activity of wild-type HSP90.2. But we leave open
the possibility of an entirely different explanation for the phe-
notype of the lra alleles than simple loss of activity. Together,
these 2 lines of evidence suggest that HSP90 ATPase activity can
be separated from HSP90 function as it pertains to the modu-
lation of NB-LRR function.
Fig. 7 presents close-up views of part of the X-ray structure of
nucleotide-bound yeast HSP90 (28). Because HSP90 is so highly
conserved across kingdoms, the Arabidopsis sequence threads
onto this sequence with high confidence. The 2 HSP90 mono-
mers in this structure are held together via an N-terminal clasp
Fig. 6. HSP90.2rsp mutant proteins retain dimerization capability. Chemical
cross-linking of wild-type and mutant forms of HSP90.2 in the presence of ADP
or the nonhydrolysable ATP analog AMP-PNP. All variants of HSP90.2 are
unable to dimerize in the presence of ADP. However, although no lra mutant
variants (A) are able to dimerize even in the presence of AMP-PNP, both rsp
mutant variants (B) can dimerize in the presence of AMP-PNP. The experiment
was performed with an HSP90 concentration of 0.25 mg/mL, 15 molar equiv-
alents of DMS, and 10 mM nucleotide.
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(and at the C terminus, although that is not relevant here). Each
monomer of HSP90 contains a lid segment, hinged at residues
G95 and G122 (Fig. 7), that swings through nearly 180° from its
open position in the ADP-bound form of HSP90, to a closed
ATP-bound conformation. This movement locks in the ATP
molecule and places the catalytic arginine (371 in Arabidopsis;
380 in yeast) in position for interaction with the -phosphate of
ATP. This movement also facilitates formation of the N-
terminal dimerization clasp (28).
The structures of nucleotide-bound HSP90 suggest a mecha-
nism for rar1 suppression by the rsp mutant proteins and present
a clear prediction for RAR1 function in NB-LRR accumulation.
We postulate that A11T and R337C act to favor the transition
between the ADP- and ATP-bound conformations of HSP90.2,
a transition characterized by the open–close cycling of the
hinged lid. HSP90 has an 5-fold higher affinity for ADP over
ATP (20). Thus, favoring the transition state, perhaps counter-
intuitively, favors the ATP bound conformation. The HSP90rsp
proteins demonstrate that lid conformation is critical for client
stabilization. Our ATP hydrolysis results suggest that ATP hydro-
lysis per se is irrelevant to HSP90 activity. Instead, the conformation
of the N-terminal domain is important. However, it is likely that
ATP hydrolysis is part of a regulatory mechanism allowing for
control of the relative time spent in either conformation.
In the nucleotide-bound HSP90 structure (Fig. 7A), V114 and
S115 from the closed lid (Fig. 7A in red) contact R337 from the
same monomer. In R337C (hsp90.2–8rsp), these interactions are
very likely to be destabilized, favoring a lid-open conformation,
consistent with an inability to continue efficient nucleotide
cycling. As shown in Fig. 7B, A11T lies within the N-terminal
strand of HSP90. This strand switches from an intramolecular
interaction in the ADP-bound, lid-open form of HSP90 to an
intermolecular interaction with the opposing subunit of the
HSP90 dimer in the ATP-bound, lid-closed form (Fig. S4). This
intermolecular interaction should act to maintain and/or
strengthen N-terminal dimerization. A11 contacts T96 near the
base of the hinge on the opposing monomer. Consequently, the
A11T mutation would be expected to both decrease the binding
of the N-terminal strand to the opposing monomer and alter the
stability of the lid-closed conformation. This conformational
effect would decrease, but not abolish N-terminal dimerization,
as we observed in Fig. 6.
We propose that destabilization of the lid-closed conforma-
tion by R337C is responsible for the diminution of dimerization,
loss of interaction with RAR1 (and SGT1b), and nearly full loss
of ATPase activity. The loss of RAR1 interaction with this
presumably misregulated ‘‘f loppy lid’’ does not have ill effects for
the function of this HSP90 allele because it is, in essence, blind
to RAR1 presence or absence. Hence, the R337C mechanism of
action defines normal RAR1 function, namely, enhancing the
cycling of the HSP90.2 lid, N-terminal dimerization cycling and
client accumulation. This proposal is consistent with A11T,
where we observed interaction with RAR1 (and SGT1b), nor-
mal nucleotide hydrolysis, some dimerization, and a recessive
phenotype (meaning that it is a less efficient rar1 suppressor than
the semidominant R337C). We propose that A11T is also able
to bypass normal RAR1 function via its less efficient ability to
maintain a lid-closed conformation.
Our model is consistent with recent observations studying the
kinetics of N-terminal dimerization using a single molecule
FRET-based HSP90 folding assay. In these in vitro experiments,
2 conformational states between the lid-open and lid-closed
conformations were studied (29, 30). These intermediate con-
formations were shown to be rate-limiting steps in the ATPase
reaction cycle (30). This work also demonstrated that the yeast
cochaperone AHA1 is able to enhance the rate of ATP hydro-
lysis by bypassing an intermediate conformational state (lid
closure) that follows ATP binding and precedes N-terminal
dimerization, in favor of a lid-closed, ATP-bound, dimerized,
prehydrolysis state. Our interpretation of the HSP90.2 rsp
proteins above is consistent with this model.
Based on this model, we expect RAR1 (and by analogy our rsp
alleles) to disfavor progression of the HSP90 cycle presented by
Hessling et al. (30) at different points before the lid-closed,
N-terminal dimerized intermediate they define as I2. R337C
dimerizes very poorly compared with wild type, is likely to act by
loosening the HSP90 lid, and is the stronger of the 2 rsp alleles.
We infer that it diminishes the ATP-bound to the lid-closed I1
intermediate transition proposed by Hessling et al. (30). A11T
dimerizes only slight less efficiently than wild type, is likely to act
by disrupting N-terminal clasp formation, and expresses less than
wild-type weak ATP hydrolytic efficiency. We infer that this
allele is unable to transition efficiently beyond the ATP-bound,
lid-closed I2 intermediate. Given these inferences, and the fact
that A11T retains interaction with RAR1 whereas R337C loses
it, we suggest that RAR1 binds to HSP90.2 at, and potentially
after, the I1 conformation. Furthermore, we suggest that RAR1
acts to slow the progression of the HSP90 conformational cycle.
These transition states can be reached in the absence of nucle-
otide (29). Hence, our data further suggest that overall HSP90
function and consequent effects on NB-LRR function are more
coupled to the HSP90 conformational state than to ATP hy-
drolysis per se.
The sum of our data and recent single-molecule folding studies
(29, 30) suggest that NB-LRR proteins are destabilized in rar1
because the HSP90 lid-open–lid-close cycle cannot be properly
regulated, consistent with a model in which the balanced activ-
ities of RAR1, SGT1, and other cochaperones acting with
HSP90 determine steady-state NB-LRR protein accumulation
and signaling competence (7).
Fig. 7. rsp mutations affect residues in the lid region of HSP90 in the closed
conformation. Ribbon structures of yeast HSP90 (Protein Data Bank ID code
2CG9) bound to ATP (light gray). This lid (red) is hinged at G95 and G122 and
swings 180° to fold over the nucleotide-binding pocket (yeast G94 and G121).
(A) R337 (yellow) coordinates interaction of the central client-binding domain
(purple, left) with the flexible lid (red) by interacting with V115 and S116 in the
lid region and E363 within the middle domain of HSP90 (yeast R346, V114,
S115, and E372). (B) A11 (yeast A10) from 1 monomer (green) interacts directly
with T96 (yeast T95; red side chain) within the hinge of the other monomer.
Black arrows indicate the locations of the hinges of the lid.






















Plant Lines. Transgenic Arabidopsis ecotype Columbia (Col-0; line a11) con-
taining estradiol-inducible avrRpm1 has been described (9). For the double
RPM1 screen, we used line a11 plant with an additional transgenic, myc-
epitope-tagged copy of RPM1 introgressed (13). For the rar1 suppressor screen
we used the originally-isolated rar1–21 mutant identified in line a11 (13). For
pathology and double mutant analysis, we used rar1–21, rar1–28, or hsp90.2–
3lra lines with the estradiol-inducible avrRpm1 removed by backcrossing to
Col-0 and subsequent PCR-based marker-assisted breeding (8, 13). Mutant
lines used (all in Col-0 unless noted) were rpm1–3 (31), rps2–101c (32), rps5–2
(14), ecotype Ws-0 as an RPP4 mutant control (18), and hsp90.2–5KO (8). We
constructed double mutants of hsp90.2 alleles and rar1–21 by identifying F2s
with a recombination event placing these linked mutations in cis. These plants
were selfed, and resultant F3 individuals were further selected with PCR-based
markers. hsp90.1KO was produced by selecting a homozygous insertion in the
SALK T-DNA insertion line 075596 [previously referred to as hsp90.1–2; ref. 5]
that was identified by molecular analysis of a segregating pool. The insertion
site was confirmed by sequencing of the T-DNA-specific product.
Pathogen Strains, Inoculation, and Growth Quantification. Pto DC3000 deriva-
tives containing pVSP61 (empty vector), avrPphB, avrRpm1 or avrRpt2 have
been described (33). Plant inoculations and bacterial growth assays were
performed as described (11). Results for all bacterial growth assays represent
3 replicates with error bars representing / the standard deviation, a 95%
confidence interval. All assays were performed independently a minimum of
3 times with similar results. High concentrations of Pto DC3000 (avrRpm1)
(OD600  0.1, 5  107 cfu/mL) were syringe-infiltrated into leaves of 4- to
5-week-old plants to induce HR. Ion leakage assays were carried out as
described (17).
Hyaloperonospora arabidopsidis (Hpa) propagation and inoculation were
performed as described (34). Ten-day-old cotyledons of plants were inocu-
lated with the asexual spores of Hpa isolate Emwa1. Asexual sporangiophores
were counted 7 days postinoculation on at least 40 cotyledons for each
genotype. Trypan blue staining for cell death and the Hp structures has been
described (35). Pictures of trypan blue-stained leaves were taken with a light
microscope (Nikon Eclipse).
Identification and Map-Based Cloning of Mutations in HSP90.2. The double
RPM1 screen was performed as described (9). The rar1 suppressor screen was
performed by using a spray inoculation method in which 2-week old plants
were sprayed with a 10 mM MgCl2 suspension containing Pto DC3000 (avrP-
phB) at a concentration of OD600  0.05 (2.5  107 cfu/mL) with 0.02% silwet
L-77, covered with a clear lid for 4 h, and assessed for chlorosis and other
symptoms of bacterial infection 4–6 days later.
Standard genetic crosses and analyses of F1 and F2 progeny were used. From
the rar1 suppressor screen, rough mapping was preformed by crossing rsp
rar1–21 mutants and the Landsberg erecta rar1–10 mutant (12). F2 plants were
tested for rsp rar1–21-like resistance responses by spray inoculation as de-
scribed above. Resistant F2 individuals were allowed to self and confirmed in
the F3 generation. DNA from the F2 individuals was used in PCR amplification
of known PCR-based molecular markers (www.arabidopsis.org) to obtain
approximate mapping positions. Independent rough mapping of the 2 mu-
tants showed linkage to the same interval. This interval was refined by using
molecular markers we developed. We used 423 resistant F2 individuals to
definea4.5-MbintervalonthebottomarmofchromosomeVcontainingHSP90.2
that is known as a regulator of RPM1 stability. By sequencing HSP90.2 in the
originally-isolated double mutant, a G/A transition at position 31 (nucleotide
positions relative to the translation start site of the published sequence of
HSP90.2; At5g56030) was identified in hsp90.2–7rsp. The other mutant, rsp2, also
contains a mutation (C1423T giving rise to R337C) in HSP90.2.
Yeast 2-Hybrid Analysis. HSP90.2 and mutant derivatives were cloned into
pJG4–5byusingtheEcoRIandXhoIrestrictionsitesandsite-directedmutagenesis
via overlap extension. RAR1, SGT1a, and SGT1b were cloned into a Gateway-
compatible version of pEG202, pEG202gw (gift of Hiro Kaminaka, Tottori Uni-
versity, Tottori, Japan; ref. 7). Interactions were analyzed in yeast strain EGY48.
Normal function of the SGT1a construct was shown by testing its interaction with
RAR1 inthepJG4–5gwvector.Assayswereperformedwithaplate reader (Tecan)
as described (36). Protein levels were analyzed as described (7).
Protein Blot. For detection of RPM1-myc levels in plants, we introgressed a
transgene expressing RPM1-myc from the native RPM1 promoter as described
(13). Protein extraction and immunodetection from plant tissue were carried
out as described (8).
Production of Recombinant Proteins. HSP90.2, mutant variants, and a 110-aa
C-terminal truncation were cloned into pGEX-6p1 as described above and
transformed into RIL codon plus cells (Strategene). Cells were grown in 2
yeast extract tryptone (YT) to an OD of 0.4 at 37 °C, and then the temper-
ature was decreased to 22 °C for 45 min, and cells were induced for 3 h with
1 mM IPTG. Cell pellets were resuspended in buffer A [20 mM Tris (pH 8.0), 300
mM NaCl, and 1 Complete EDTA-Free protease inhibitor tablet (Roche)]. After
resuspension, cells were lysed by using an Avestin Emulsiflex-C5. The lysates
were cleared by centrifugation for 45 min at 15,000 rpm in an SS-34 rotor. The
cleared lysates were run on a 5-mL High Trap glutathione column (GE Health-
care) and washed with 10 column volumes of buffer A. The protein was eluted
with 5 column volumes of buffer A with 20 mM glutathione. PreScission
protease (50 units/mL; GE Healthcare) was then added to the sample, and the
protein was cleaved overnight at 4 °C while being dialyzed into buffer B [20
mM sodium phosphate (pH 6.5), 150 mM NaCl, 2 mM DTT]. The next morning,
the protein was loaded onto a HiLoad 16/10 Q Sepharose High Performance
anion exchange column equilibrated in buffer B and eluted with a 150- to
600-mM linear gradient. Fractions were analyzed for purity by SDS/PAGE, and
clean fractions were pooled and dialyzed into buffer C (40 mM Hepes, 150 mM
KCl, and 5 mM MgCl2 at pH 7.5).
Biochemical Methods. Circular dichroism experiments were performed on a
Pistar-180 circular dichroism/fluorescence spectrophotometer (Applied Photo-
physics). Samples at 20 M were placed in a 0.1-cm cuvette, and scans were
taken from 195 to 260 nm with 1-nm increments and 30,000 repetitions per
increment.
ATP hydrolysis assays were performed as described (27, 37). Briefly, 2.5 M
purified HSP90 was incubated with 0.4 mM phosphoenol pyruvate, 0.25 mM
NADH, and 1% PK/LDH enzyme mix (Sigma). Proteins were incubated with
multiple concentrations of ATP between 0 and 1.2 mM. Experiments were
performed in duplicate with a control containing 0.5 mM radicicol to measure
HSP90-specific activity. Experiments were performed in 200-L reactions in a
plate reader (GENios; Tecan).
Cross-linking experiments were performed as described (24). Purified
HSP90 (0.25 mg/mL) was incubated for 2 h with 10 mM ADP or AMP-PNP, after
which a 15 molar excess of dimethyl suberimidate dihydrochloride (DMS) was
added for an additional 2-h incubation. Reactions were stopped by addition
of SDS/PAGE loading buffer and loading on an 8% gel.
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